Carl Zeiss Meditec AG (AFX) — Capital Reinvestment Ratio
Carl Zeiss Meditec AG (AFX) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (€209.86 Million) in capital expenditures (€76.59 Million). Check tangible net worth ratio of Carl Zeiss Meditec AG to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Carl Zeiss Meditec AG Capital Reinvestment Ratio (2014–2025)
This chart tracks Carl Zeiss Meditec AG's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Carl Zeiss Meditec AG cash flow conversion.
Annual Capital Reinvestment Ratio for Carl Zeiss Meditec AG (2014–2025)
Year-by-year Capital Reinvestment Ratio for Carl Zeiss Meditec AG from 2014 to 2025. See AFX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | €209.86 Million | €76.59 Million | ▼ -40.7% |
| 2024 | 0.62x | €247.32 Million | €152.20 Million | ▲ +135.2% |
| 2023 | 0.26x | €250.86 Million | €65.65 Million | ▲ +15.1% |
| 2022 | 0.23x | €188.20 Million | €42.80 Million | ▲ +173.8% |
| 2021 | 0.08x | €362.66 Million | €30.12 Million | ▼ -49.4% |
| 2020 | 0.16x | €178.53 Million | €29.32 Million | ▲ +77.3% |
| 2019 | 0.09x | €219.63 Million | €20.35 Million | ▲ +4.9% |
| 2018 | 0.09x | €187.21 Million | €16.54 Million | ▼ -75.6% |
| 2017 | 0.36x | €37.73 Million | €13.66 Million | ▲ +44.9% |
| 2016 | 0.25x | €111.77 Million | €27.92 Million | ▲ +45.0% |
| 2015 | 0.17x | €56.74 Million | €9.77 Million | ▼ -2.5% |
| 2014 | 0.18x | €63.10 Million | €11.14 Million | — |